FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022893313> ?p ?o ?g. }

• W2022893313 endingPage "197" @default.
• W2022893313 startingPage "189" @default.
• W2022893313 abstract "A phosphorothioate oligonucleotide (PS-ODN) with sequence identical to the repeat sequence of the mammalian telomere, 5′-d(TTAGGG)-3′, was incubated with a Burkitt's lymphoma-derived (OMA-BL1) cell line. This hexanucleotide inhibits telomerase activity in cell lysates, lengthens cell doubling time, and induces apoptosis. Concatenated repeats (12-, 18-, and 24-mers) of the 5′-d(TTAGGG)-3′ motif induce similar cellular responses. Scrambled sequences do not efficiently inhibit telomerase activity or significantly alter cell growth and viability. Thein vivoefficacy of this PS-ODN was evaluated in a xenograft human–nude mouse model. Once tumors were established these animals were administered the telomere mimic, 5′-d(TTAGGG)-3′, a control scrambled sequence 5′-d(TGTGAG)-3′, or saline for 14 days via a subcutaneous osmotic pumps in a blinded study monitoring tumor size with dose and time. A significant decrease in tumor size was observed in animals given 50 μg/mouse/day 5′-d(TTAGGG)-3′, but not following 5′-d(TGTGAG)-3′, relative to the saline-treated animals. The antitumor activity of the 6-mer telomere mimic demonstrated a dose dependency including a reduction in metastatic nodules in the spleen. No activity was observed with the scrambled controls. In addition to antitumor activity we observed an increase in the mouse hematopoietic progenitor cell populations, BFU-e and CFU-GM. These results demonstrated the effects of a short hexameric oligonucleotide telomere mimicin vitroandin vivoand the potential utility of short oligonucleotides as telomerase inhibitors." @default.
• W2022893313 created "2016-06-24" @default.
• W2022893313 creator A5000219641 @default.
• W2022893313 creator A5030775041 @default.
• W2022893313 creator A5036099566 @default.
• W2022893313 creator A5050455344 @default.
• W2022893313 creator A5072496994 @default.
• W2022893313 creator A5078632127 @default.
• W2022893313 creator A5080973515 @default.
• W2022893313 creator A5082192456 @default.
• W2022893313 creator A5088904535 @default.
• W2022893313 date "1997-05-01" @default.
• W2022893313 modified "2023-10-16" @default.
• W2022893313 title "A Hexameric Phosphorothioate Oligonucleotide Telomerase Inhibitor Arrests Growth of Burkitt's Lymphoma Cellsin Vitroandin Vivo" @default.
• W2022893313 cites W1966427625 @default.
• W2022893313 cites W1968270507 @default.
• W2022893313 cites W1972724663 @default.
• W2022893313 cites W1990122494 @default.
• W2022893313 cites W1990579613 @default.
• W2022893313 cites W1996384141 @default.
• W2022893313 cites W2008085654 @default.
• W2022893313 cites W2008132588 @default.
• W2022893313 cites W2015037479 @default.
• W2022893313 cites W2025535668 @default.
• W2022893313 cites W2028065809 @default.
• W2022893313 cites W2028860713 @default.
• W2022893313 cites W2029735450 @default.
• W2022893313 cites W2034487226 @default.
• W2022893313 cites W2047469560 @default.
• W2022893313 cites W2050275508 @default.
• W2022893313 cites W2060017837 @default.
• W2022893313 cites W2061161155 @default.
• W2022893313 cites W2075157322 @default.
• W2022893313 cites W2095329435 @default.
• W2022893313 cites W2107634357 @default.
• W2022893313 cites W2111723163 @default.
• W2022893313 cites W2143063758 @default.
• W2022893313 cites W2338806373 @default.
• W2022893313 cites W260828612 @default.
• W2022893313 cites W4297901344 @default.
• W2022893313 doi "https://doi.org/10.1006/taap.1997.8103" @default.
• W2022893313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9169084" @default.
• W2022893313 hasPublicationYear "1997" @default.
• W2022893313 type Work @default.
• W2022893313 sameAs 2022893313 @default.
• W2022893313 citedByCount "74" @default.
• W2022893313 countsByYear W20228933132013 @default.
• W2022893313 countsByYear W20228933132014 @default.
• W2022893313 countsByYear W20228933132016 @default.
• W2022893313 countsByYear W20228933132018 @default.
• W2022893313 countsByYear W20228933132019 @default.
• W2022893313 countsByYear W20228933132020 @default.
• W2022893313 countsByYear W20228933132021 @default.
• W2022893313 crossrefType "journal-article" @default.
• W2022893313 hasAuthorship W2022893313A5000219641 @default.
• W2022893313 hasAuthorship W2022893313A5030775041 @default.
• W2022893313 hasAuthorship W2022893313A5036099566 @default.
• W2022893313 hasAuthorship W2022893313A5050455344 @default.
• W2022893313 hasAuthorship W2022893313A5072496994 @default.
• W2022893313 hasAuthorship W2022893313A5078632127 @default.
• W2022893313 hasAuthorship W2022893313A5080973515 @default.
• W2022893313 hasAuthorship W2022893313A5082192456 @default.
• W2022893313 hasAuthorship W2022893313A5088904535 @default.
• W2022893313 hasConcept C104317684 @default.
• W2022893313 hasConcept C129312508 @default.
• W2022893313 hasConcept C153911025 @default.
• W2022893313 hasConcept C177336024 @default.
• W2022893313 hasConcept C207001950 @default.
• W2022893313 hasConcept C502942594 @default.
• W2022893313 hasConcept C54355233 @default.
• W2022893313 hasConcept C552990157 @default.
• W2022893313 hasConcept C55493867 @default.
• W2022893313 hasConcept C62112901 @default.
• W2022893313 hasConcept C81885089 @default.
• W2022893313 hasConcept C86803240 @default.
• W2022893313 hasConcept C94581717 @default.
• W2022893313 hasConceptScore W2022893313C104317684 @default.
• W2022893313 hasConceptScore W2022893313C129312508 @default.
• W2022893313 hasConceptScore W2022893313C153911025 @default.
• W2022893313 hasConceptScore W2022893313C177336024 @default.
• W2022893313 hasConceptScore W2022893313C207001950 @default.
• W2022893313 hasConceptScore W2022893313C502942594 @default.
• W2022893313 hasConceptScore W2022893313C54355233 @default.
• W2022893313 hasConceptScore W2022893313C552990157 @default.
• W2022893313 hasConceptScore W2022893313C55493867 @default.
• W2022893313 hasConceptScore W2022893313C62112901 @default.
• W2022893313 hasConceptScore W2022893313C81885089 @default.
• W2022893313 hasConceptScore W2022893313C86803240 @default.
• W2022893313 hasConceptScore W2022893313C94581717 @default.
• W2022893313 hasIssue "1" @default.
• W2022893313 hasLocation W20228933131 @default.
• W2022893313 hasLocation W20228933132 @default.
• W2022893313 hasOpenAccess W2022893313 @default.
• W2022893313 hasPrimaryLocation W20228933131 @default.
• W2022893313 hasRelatedWork W1536144403 @default.
• W2022893313 hasRelatedWork W2005903392 @default.
• W2022893313 hasRelatedWork W2050296416 @default.
• W2022893313 hasRelatedWork W2090447055 @default.

• next